AGP Executive Report

DOJ Rescheduling Shock: Arkansas experts say moving medical marijuana to Schedule III could cut cannabis business taxes by easing the impact of federal 280E, a big deal for operators watching their effective tax rates. Regulatory Crackdown: New York’s OCM shut and padlocked a Middletown shop after an undercover attempt to sell illicit cannabis to a 16-year-old. Investor Fallout Court Drama: Cronos CEO Mike Gorenstein testified in the Andrew Left securities fraud trial, describing how a short-seller tweet triggered panic selling and “damage control” for investors. Public Safety Enforcement: NYC eviction officers recovered about 300 pounds of illegal marijuana from a Bronx building. Legislative Push: A House floor vote is advancing that would let VA doctors help military veterans access state medical marijuana recommendations. Industry/Finance: iAnthus and Jushi both posted Q1 2026 results, underscoring how rescheduling and compliance are colliding with earnings pressure. Local Retail Moves: Batavia opened its first dispensary after a referendum, while Hamilton, Ohio, is drafting tighter zoning rules for marijuana and related retailers.

Storm Relief Push (Cape Town): The City of Cape Town has opened multiple donation drop-off points at fire stations across the metro, asking for non-perishables, hygiene items, nappies/baby formula, blankets and bedding as flooding has hit at least 26 informal areas and over 10,700 structures. Anti-Doping Shock (Rugby/Georgia): World Rugby handed Merab Sharikadze an 11-year ban and other Georgia players long suspensions after a urine-swapping scheme tied to advance tips on tests. Retail Security (Michigan): Monroe County deputies are hunting suspects after a stolen Jeep rammed a marijuana retailer and sparked a fire. Regulatory/Market Moves: Iowa lawmakers sent a bill to double medical dispensary caps to 10; Minnesota approved Simply Crafted’s LPHE wholesale license and importer endorsement; and Ohio launched a $20M public education campaign on marijuana risks. Enforcement/Seizures: Delhi police destroyed ~1,700 kg of drugs and announced an anti-narcotics task force station.

Texas Hemp Court Fight: Texas’ smokeable hemp case is back in legal limbo as the state appeals a ruling that had kept flower on shelves until July—then enforcement was paused, and the products reportedly returned briefly before the appeal kicked back in. Public Health & Safety: Emergency rooms in the Philadelphia region are seeing more cannabinoid hyperemesis syndrome cases, while a Georgia father warns THC vapes may be laced with fentanyl after kids tested positive. Local Enforcement: Baltimore moves to regulate smoke shops—adding distance limits from schools/parks and a “padlock” path for repeat offenders—while New York shuts a Middletown smoke shop for allegedly selling unlicensed cannabis to a 16-year-old. Industry & Policy: Thailand denies any “free cannabis” plan and signals tighter controls as a cannabis and hemp bill heads toward parliament. Science Watch: A UC Riverside preclinical study suggests cannabis compounds may improve metabolism and lower diabetes risk, even as THC alone didn’t fix glucose regulation in mice.

Enforcement Spotlight: Police in Ghana’s Eastern Region arrested three suspects after seizing 1,600 parcels of suspected Indian hemp, following surveillance and a reported GH¢100,000 bribery attempt tied to a shipment allegedly bound for Nigeria. Retail & Safety: Chicago police say a group smashed windows at a South Loop cannabis dispensary early Monday; it’s unclear if anything was taken and the investigation is ongoing. Market Moves: Vertex Exotics announced a Texas-focused THCA/Delta-9 e-commerce fulfillment plan built around verified adult access, clearer product education, and regional compliance as rules shift. Industry & Product Education: A new explainer on THC forms highlights how delta-8, delta-9, delta-10, and THCA differ—and why product THC amounts can vary. Global Policy/Politics: In Virginia, the FBI search of Sen. Louise Lucas’ office is fueling claims of political intimidation amid the state’s redistricting fight. Health Research: A small double-blind trial reports coconut water may improve gut inflammation symptoms in mild-to-moderate ulcerative colitis—an early, diet-based signal for the wellness-to-clinic conversation.

Over the last 12 hours, the biggest CBD/cannabis thread is the U.S. federal rescheduling storyline and its immediate downstream effects. Multiple items point to marijuana being moved from Schedule I to Schedule III for medical cannabis, with one piece noting the DEA is preparing an administrative hearing to consider broader rescheduling. Alongside that, coverage emphasizes what the change could unlock for the industry—especially banking and taxes—through improved access to financial services and relief from Section 280E constraints (as described in the provided analysis and “IRS Foreshadows Section 280E Guidance” item). In parallel, there’s also consumer-facing scrutiny: a lawsuit coverage says marijuana vendors are being sued in Illinois and Connecticut for allegedly failing to warn consumers about health risks.

A second major development in the last 12 hours is legal and enforcement activity that touches cannabis businesses directly. The most prominent example is the FBI raid coverage of Virginia Sen. L. Louise Lucas’ office and a nearby dispensary connected to her—framed in the articles as part of a corruption investigation, with Lucas responding publicly and disputing motives. There’s also evidence of ongoing cannabis-related criminal enforcement and disruption: reports include a “highly organised and professional” cannabis factory/cultivation operation uncovered in North Yorkshire (with multiple arrests), and a separate burglary case involving a cannabis dispensary in Turner (described as the second burglary in less than a week).

The last 12 hours also show a mix of routine industry/legal updates and market commentary rather than one single cohesive “industry event.” Examples include a rival dispensary dispute in New Jersey (OHM Theory suing a competitor and suppliers over alleged efforts to squeeze it out), and additional smaller-scale criminal cases (e.g., arrests tied to drug-related charges). On the market side, there’s coverage of cannabis-linked finance and corporate updates: articles reference potential investor/credit implications from rescheduling (including discussion of how Schedule III could strengthen operator balance sheets) and include company financial-result coverage for cannabis operators and related finance entities.

Looking slightly further back (12 to 72 hours ago), the same rescheduling theme continues, but with more background on how states are handling THC caps and medical/adult-use frameworks, plus additional enforcement and regulatory actions. There’s also continuity in the “cannabis business risk” narrative: earlier items include lawsuits and regulatory disputes, and more reports of raids, seizures, and arrests. However, the provided evidence is heavily concentrated in the U.S. rescheduling and the Virginia raid cluster; beyond that, many headlines appear to be standalone local enforcement or business updates rather than corroborated, large-scale shifts.

Bottom line: In the most recent window, the coverage is dominated by (1) federal medical marijuana rescheduling and what it could change for taxes/banking, and (2) high-profile federal enforcement involving a Virginia lawmaker and a dispensary. Other items—lawsuits between dispensaries, consumer-warning litigation, and localized raids/burglaries—support a broader picture of heightened legal exposure and operational uncertainty even as policy change potentially improves industry economics.

Over the last 12 hours, the dominant CBD/cannabis-related development is a major federal law-enforcement action in Virginia tied to state Sen. L. Louise Lucas. Multiple reports say the FBI executed court-authorized search warrants at Lucas’s Portsmouth legislative office and at an adjacent cannabis dispensary she co-owns, with the activity described as part of an ongoing corruption investigation. The FBI statement cited “court-authorized federal search warrant” activity and said there was “no threat to public safety,” while also providing no further public details. Several outlets also frame the raid as connected to marijuana dispensary operations, and Lucas is described as a long-time marijuana legalization advocate and a key figure in Virginia’s redistricting push—though the articles emphasize that no arrests or charges were publicly identified at the time of reporting.

Alongside the Virginia raid, the coverage includes more routine but still industry-relevant enforcement and market-safety stories. In Canada, a Winnipeg police officer testified in a trial denying he stole cannabis from a guarded crime scene, while prosecutors allege officers took cannabis after being left to secure the scene until a search warrant. In another retail-safety item, a cannabis store employee in Winnipeg was sexually assaulted during a robbery attempt, prompting renewed calls for stronger safety requirements for cannabis workers. Separately, Nigeria Customs Service reporting highlights seizures that included “synthetic strain of cannabis indica” and other contraband, underscoring continued cross-border enforcement pressure affecting cannabis supply chains.

There are also signals of ongoing legal and commercial movement within the broader cannabis economy, though the evidence in the most recent window is thinner. A cannabis-industry business update discusses Curaleaf earnings and Ohio’s reported April sales surge, attributing growth in part to pre-roll demand and a late-March ban on intoxicating hemp products—framing how hemp restrictions can shift state-market dynamics. Another recent item notes a court-related resolution in Illinois THC potency labeling litigation (described as stipulated dismissals following favorable rulings), suggesting continued legal consolidation around product compliance.

Looking back 12 to 72 hours (as supporting context), the same Virginia raid theme persists across multiple outlets, reinforcing that it’s the key “headline” event in this rolling window rather than a one-off mention. That earlier coverage also adds background on Lucas’s role in redistricting and her public marijuana advocacy, while still not providing definitive allegations beyond references to corruption/bribery and dispensary-related inquiry. Outside Virginia, the older range contains additional enforcement and policy-adjacent items (e.g., rescheduling-related legal challenges and state-level regulatory debates), but the provided evidence is much more detailed for the Virginia raid than for any single new policy shift in the last 12 hours.

Over the last 12 hours, coverage touching CBD/cannabis is dominated by a mix of policy/industry signals and localized enforcement or health-related stories. The clearest industry theme is the ongoing fallout from U.S. marijuana rescheduling: multiple articles reference how companies are positioning for Schedule III medical cannabis operations, including Glass House Brands submitting applications for DEA registration under an expedited pathway, and a broader explainer noting that the DOJ order changes federal compliance mechanics for medical cannabis (while not immediately bringing the whole state-legal industry into full federal compliance). In parallel, Simply Crafted urged Minnesota lawmakers to adopt a federal “opt-out” approach to protect the state’s hemp-derived market, framing it as a way to preserve existing state oversight amid projected federal regulatory impacts.

Product and market-facing developments also appear in the last 12 hours, but they’re more incremental than headline-grabbing. Cronos announced expansion of its Spinach STIX pre-roll format across more Canadian provinces, and Planet 13 flagged its upcoming first-quarter 2026 results date. There are also consumer-facing and brand stories that connect to CBD specifically—most notably Katie Price’s social-media controversy around CBD use and a tattoo, and Urban Triage’s launch of a hemp/CBD wellness brand (“Less Noise Wellness”) tied to its agricultural programming. On the health side, one article reports that alcohol remains the primary substance driving addiction support demand in Cork, with cannabis cited as a smaller share of presentations—suggesting cannabis is present in treatment demand but not leading it in that dataset.

Enforcement and risk-related reporting is also heavy in the most recent window, though it’s largely local and case-based rather than indicating a single coordinated global shift. Examples include a R13 million cocaine bust at Durban Harbour prompting a manhunt (with details on concealed drugs in buses), a Bartica river patrol where cannabis parcels were recovered and suspects arrested, and multiple drug-related arrests/charges in other jurisdictions (e.g., a warrant for synthetic cannabinoids and cocaine in Louisiana; a Bracknell sentencing for repeated Class A/Class B drug offences). Separately, there’s a warning about “spice” (synthetic cannabinoids) in Bristol after reports of hospitalisations and a suspected death—again emphasizing harm-reduction and public safety rather than CBD market growth.

Looking slightly further back (12–72 hours and 3–7 days), the pattern of “rescheduling as the main strategic storyline” continues, with additional context on how federal changes are being interpreted and contested (including congressional research framing the scope/limitations of the Trump administration’s marijuana rescheduling move, and mentions of lawsuits and state-level regulatory uncertainty). There’s also continuity in the public-health and youth-substance-use angle: a Washington state survey article reports declining youth substance use and improving mental health indicators, while other coverage highlights ongoing debates about cannabis’s risks and marketing. However, because the most recent 12-hour evidence is sparse on new CBD-specific regulatory outcomes beyond the U.S. rescheduling positioning, the overall sense is that the biggest “change” right now is industry preparation for rescheduling—while most other items are routine enforcement, brand launches, and localized health warnings.